Intellia Therapeutics, Inc. (NTLA)
13.43
+0.67
(+5.25%)
USD |
NASDAQ |
Mar 16, 14:12
Intellia Therapeutics Market Cap : 1.587B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.648B |
| Recursion Pharmaceuticals, Inc. | 1.799B |
| Personalis, Inc. | 715.68M |
| Regeneron Pharmaceuticals, Inc. | 80.04B |
| Pacific Biosciences of California, Inc. | 409.21M |
Market Cap Related Metrics
| PS Ratio | 21.50 |
| Price to Book Value | 2.363 |
| Price | 13.43 |
| Earnings Yield | -28.49% |